Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Clinical trial NCT02644369 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02644369
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Cancer of Head and Neck Triple Negative Breast Cancer Epithelial Ovarian Cancer Malignant Melanoma Advanced Solid Tumors

Start date: 2016-03-21
Primary completion: 2026-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.